SHEKHAR B. SARAF
Dabur India Limited – Appellant
Versus
Shree Baidyanath Ayurved Bhawan Pvt. Ltd. – Respondent
JUDGMENT
Shekhar B. Saraf, J.
Facts:
1. The plaintiff/petitioner has filed the present suit against an advertising campaign containing five impugned advertisements issued by the defendant/respondent one after the other during October and November 2021 in relation to its product "Baidhyanath Chyawanprash Special". Details of the impugned advertisements are as follows:
Dabur India Ltd. vs. Emami Ltd.
Reckitt Benckiser (India) Pvt. Ltd. vs. Hindustan Lever Limited
Point of law: Under Section 3 (a) of the Drugs & Cosmetic Act, 1940 and as agreed by both parties, there can be no Chyawanprash available in the market with 42 ingredients
The main legal point established in the judgment is that while comparative advertising is permissible, an advertiser cannot denigrate or disparage a rival product. The court emphasized the importance....
The use of the term 'Sadharan' in advertisements does not inherently imply disparagement if the context suggests substantial differences between competing products.
Descriptors like 'ordinary' or 'sadharan' do not constitute disparagement unless linked to a specific product, balancing trademark protection with freedom of speech.
Commercial advertisements must promote without disparaging competitors; misleading claims are impermissible under protection afforded to commercial speech.
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.